Chemours (CC) Stock Price, News & Analysis

Company Overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Key Stats

• Today's Range: $11.99 to $12.58
• 50-Day Range: $9.41 to $14.63
• 52-Week Range: $9.13 to $22.38
• Volume: 3.59 million shs
• Average Volume: 4.04 million shs
• Market Capitalization: $1.82 billion
• P/E Ratio: N/A
• Dividend Yield: 2.88%
• Price Target: $17.38
• Consensus Rating: Moderate Buy

Chemours Stock Analysis - MarketRank™

Chemours scored higher than 91% of companies evaluated by MarketBeat, and ranked 19th out of 184 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Chemours has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Chemours has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 33.50%

Earnings Growth

Earnings for Chemours are expected to grow by 33.50% in the coming year, from $2.03 to $2.71 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Chemours is -4.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Chemours is -4.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Chemours has a P/B Ratio of 7.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

10.77% of the float of Chemours has been sold short.

Short Interest Ratio / Days to Cover

Chemours has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Chemours has recently decreased by 12.62%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Chemours pays a meaningful dividend of 2.92%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Chemours does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Chemours will have a dividend payout ratio of 12.92% next year. This indicates that Chemours will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

10.77% of the float of Chemours has been sold short.

Short Interest Ratio / Days to Cover

Chemours has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Chemours has recently decreased by 12.62%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.44

News Sentiment

Chemours has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 22 news articles for Chemours this week, compared to 8 articles on an average week.

Search Interest

18 people have searched for CC on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.

MarketBeat Follows

Only 5 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Chemours insiders have bought more of their company's stock than they have sold. Specifically, they have bought $251,573.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.47% of the stock of Chemours is held by insiders.

Percentage Held by Institutions

76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CC Stock Analysis - Frequently Asked Questions

How have CC shares performed this year?

Chemours' stock was trading at $16.90 at the beginning of 2025. Since then, CC stock has decreased by 28.0% and is now trading at $12.1620.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) released its quarterly earnings results on Tuesday, August, 5th. The specialty chemicals company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.12. The company's revenue for the quarter was up 5.0% on a year-over-year basis.
Read the conference call transcript.

Who are Chemours' major shareholders?

Chemours' top institutional shareholders include Bank of Montreal Can (0.83%), Bank of New York Mellon Corp (0.70%), Allianz Asset Management GmbH (0.31%) and Peregrine Capital Management LLC (0.26%). Insiders that own company stock include Mark Newman, Damian Gumpel, Shane Hostetter, Alisha Bellezza, Matthew S Abbott, Diane I Picho and Alvenia Scarborough.
View institutional ownership trends.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Ex-Dividend for 6/16 Dividend: 5/16/2025
• Record date for 6/16 Dividend: 5/19/2025
• Dividend Payable: 6/16/2025
• Last Earnings: 8/05/2025
• Today: 8/08/2025
• Record date for 9/12 Dividend: 8/15/2025
• Ex-Dividend for 9/12 Dividend: 8/15/2025
• Dividend Payable: 9/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Basic Materials
• Industry: CHEM - DIVERSIFD
• Sub-Industry: Chemicals
• Current Symbol: NYSE:CC
• CIK: 1627223
• Web: www.chemours.com
• Phone: (302) 773-1000
• Fax: N/A
• Employees: 6,000
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Chemours: $17.38
• High Price Target: $27.00
• Low Price Target: $13.00
• Potential Upside/Downside: +42.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.63
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.80)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 5.99
• P/E Growth: N/A
• Net Income: $86 million
• Net Margins: -7.19%
• Pretax Margin: -4.67%
• Return on Equity: 35.14%
• Return on Assets: 2.45%

Debt

• Debt-to-Equity Ratio: 17.16
• Current Ratio: 1.68
• Quick Ratio: 0.83

Sales & Book Value

• Annual Sales: $5.78 billion
• Price / Sales: 0.31
• Cash Flow: $3.74 per share
• Price / Cash Flow: 3.25
• Book Value: $1.60 per share
• Price / Book: 7.60

Miscellaneous

• Outstanding Shares: 149,700,000
• Free Float: 148,971,000
• Market Cap: $1.82 billion
• Optionable: Optionable
• Beta: 1.61